Read More

Invest In These 2 High Yielding Data Center REITS As The Credit Risk For Tech Companies Increases

Although interest rates are rising, it doesn't mean savvy investors cannot earn positive returns on real estate investment trusts (REITs). Historically, when the risk-free rate rose dramatically in six time periods, REITs earned positive returns during four of those periods, and out of half of those periods, they beat the S&P 500.

EQIX

Read More

Bill Ackman’s Protégé Holds These 3 High Yielding Stocks For Passive Income And Steady Gains

Sachem Head Capital Management, founded and managed by Scott Ferguson in 2012, is a value-oriented investment management firm based in New York City. After graduating from Stanford University in 2003, where he met Bill Ackman, Ferguson became the first analyst and partner of Pershing Square Capital.

HAS

Read More

A Look At Upcoming IPOs For The Week

With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.

LRE

Read More

Magic Mushrooms For Anorexia? Clinical Study Receives FDA Approval For Phase 2 Trial

Origin Therapeutics Holdings Inc. (CSE: ORIG), a psychedelics industry-focused investment issuer, announced that one of its portfolio companies, Xpira Pharmaceuticals, has obtained approval from the FDA for its first Investigational New Drug (IND) application for a Phase 2a psilocybin therapy clinical study for anorexia nervosa.

CSE:ORIG